Nesher, Israel

Alexandra Ereskovsky


Average Co-Inventor Count = 16.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Alexandra Ereskovsky: Innovator in Androgen-Dependent Disorder Treatments

Introduction

Alexandra Ereskovsky is a notable inventor based in Nesher, IL. She has made significant contributions to the field of medical treatments, particularly focusing on androgen-dependent disorders. Her innovative work has led to the development of a unique patent that addresses these health issues.

Latest Patents

Ereskovsky holds a patent for a composition and method for treating androgen-dependent disorders. This patent, titled "Composition and method for treating androgen-dependent disorders," involves chimeric polypeptides that include a dihydrotestosterone (DHT) reductase moiety, such as 3 alpha-hydroxysteroid dehydrogenase (3α-HSD), fused to a signal peptide moiety. The invention also encompasses polynucleotides encoding the chimeric polypeptide and compositions that include at least one microorganism cell capable of secreting the chimeric polypeptide. The methods and kits provided by this patent aim to treat, prevent, or ameliorate androgen-dependent disorders, including androgenic alopecia.

Career Highlights

Ereskovsky is associated with the Technion Research & Development Foundation Limited, where she continues to advance her research and innovations. Her work is characterized by a commitment to improving health outcomes for individuals affected by androgen-dependent conditions.

Collaborations

Throughout her career, Ereskovsky has collaborated with talented individuals such as Roee Amit and Alexey Tomsov. These partnerships have contributed to the success and impact of her research.

Conclusion

Alexandra Ereskovsky is a pioneering inventor whose work in treating androgen-dependent disorders showcases her dedication to medical innovation. Her patent reflects a significant advancement in the field, promising better treatment options for those affected by these conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…